HonCode

Go Back   HER2 Support Group Forums > Breast Cancer Newsfeed
Reload this Page Novartis Europharm Ltd. Withdraws Its Application For An Extension Of Indication For
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 12-16-2010, 06:10 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,103
Novartis Europharm Ltd. Withdraws Its Application For An Extension Of Indication For
The European Medicines Agency (EMA) has been formally notified by Novartis Europharm Ltd. of its decision to withdraw its application for an extension of indication for the centrally authorised medicine Zometa (zoledronic acid) 4 mg powder and solvent for solution for infusion and 4 mg/ 5 ml concentrate for solution for infusion. On 22 December 2009, Novartis Europharm Ltd...

More...
News is offline   Reply With Quote
Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -7. The time now is 11:16 PM.
Contact Us - HER2 Support Group - Archive - Privacy Statement - Top

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter